Evidence map›Paper›PMID 27447826›Full record

ArticleEpidemiology and infection2016

Clinical characteristics, virulence factors and molecular typing of methicillin-resistant Staphylococcus aureus infections in Shenzhen City, China.

L Hu, Y Li, Y Lu, J D Klena, Y Qiu, Y Lin, M Jiang, X Shi, L Chen, X Liu and 5 more

Abstract read
In one paragraph

Article in Epidemiology and infection, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Severe problem of macrolides resistance to common pathogens in China.Frontiers in cellular and infection microbiology · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

L HuCollege of Life Sciences,Shenzhen University,Shenzhen,Guangdong,China.
Y LiShenzhen Major Infectious Disease Control Key Laboratory,Shenzhen Center for Disease Control and Prevention,Shenzhen,Guangdong Province,China.
Y LuShenzhen Major Infectious Disease Control Key Laboratory,Shenzhen Center for Disease Control and Prevention,Shenzhen,Guangdong Province,China.
J D KlenaUnited States Centers for Disease Control and Prevention,Beijing,China.
Y QiuShenzhen Major Infectious Disease Control Key Laboratory,Shenzhen Center for Disease Control and Prevention,Shenzhen,Guangdong Province,China.
Y LinShenzhen Major Infectious Disease Control Key Laboratory,Shenzhen Center for Disease Control and Prevention,Shenzhen,Guangdong Province,China.
M JiangShenzhen Major Infectious Disease Control Key Laboratory,Shenzhen Center for Disease Control and Prevention,Shenzhen,Guangdong Province,China.
X ShiShenzhen Major Infectious Disease Control Key Laboratory,Shenzhen Center for Disease Control and Prevention,Shenzhen,Guangdong Province,China.
L ChenShenzhen Major Infectious Disease Control Key Laboratory,Shenzhen Center for Disease Control and Prevention,Shenzhen,Guangdong Province,China.
X LiuShenzhen Major Infectious Disease Control Key Laboratory,Shenzhen Center for Disease Control and Prevention,Shenzhen,Guangdong Province,China.
H MaShenzhen Major Infectious Disease Control Key Laboratory,Shenzhen Center for Disease Control and Prevention,Shenzhen,Guangdong Province,China.
J ChengShenzhen Major Infectious Disease Control Key Laboratory,Shenzhen Center for Disease Control and Prevention,Shenzhen,Guangdong Province,China.
S WuUnited States Centers for Disease Control and Prevention,Beijing,China.
B KanKey Laboratory of Surveillance and Early-warning on Infectious Disease,Division of Infectious Disease,Chinese Center for Disease Control and Prevention,Beijing,China.
Q HuCollege of Life Sciences,Shenzhen University,Shenzhen,Guangdong,China.

Funding

CGH CDC HHS U2G GH000018
6 · The paper itself

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a serious hospital and community-acquired infection and some strains are associated with greater severity. We investigated the clinical variability and molecular characteristics of MRSA infections in Shenzhen, China through a study at nine sentinel hospitals from January to December 2014. MRSA infections were classified as community-associated (CA-MRSA), healthcare-associated (HA-MRSA), and healthcare-associated community-onset (HACO-MRSA). In total, 812 MRSA isolates were collected and 183 of these were selected for further study. Patients with HA-MRSA infections were generally of greater age compared to other groups. Distinct body site and clinical presentations were evident in infected patients, e.g. CA-MRSA (skin and soft tissue, 53%), HA-MRSA (respiratory tract, 22%; surgical site, 20%; trauma wounds, 20%) and HACO-MRSA (mastitis, 47%). In contrast to HA-MRSA, other categories of strains were significantly more susceptible to gentamicin, sulfamethoxazole/trimethoprim, and tetracycline. No resistance to vancomycin or linezolid was recorded. The predominant clonal lineage within each strain category was CC59-t437-SCCmec IV/V-agr I (CA, 51·4%; HA, 28·9%; HACO, 52·9%) which exhibited characteristics of a traditional CA clone together with agr I which is more often associated with HA clones. In conclusion, for the three categories of MRSA infections, there were significant differences in clinical characteristics of patients, but the predominant clone in each category shared a similar genetic background which suggests that transmission of MRSA strains has occurred between the community and hospitals in Shenzhen.

Indexed as

AdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsChildChild, PreschoolChinaCommunity-Acquired InfectionsCross InfectionFemaleGenes, BacterialHumansInfantInfant, NewbornMaleAnti-Bacterial AgentsMethicillinVirulence FactorsCA-MRSAclinical characteristicsHACO-MRSAHA-MRSAmethicillin-resistant Staphylococcus aureusmolecular typingvirulence factors

Identifiers

PMID27447826
PMCPMC9150277

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.